[Structural Study in the Platform for Drug Discovery, Informatics, and Structural Life Science]

Area of Science:

• Structural Biology
• Biophysics
• Drug Discovery

Background:

• The Platform for Drug Discovery, Informatics, and Structural Life Science (PDIS) was established in FY2012 as a national initiative.
• It aims to assist life science researchers lacking expertise in structural biology.

Purpose of the Study:

• To provide comprehensive, full-scale support for structural biology research.
• To facilitate access to advanced structural biology techniques and resources for a wider research community.

Main Methods:

• PDIS offers services including protein purification, crystallization, structure determination (X-ray crystallography, SAXS, NMR, electron microscopy), and bioinformatics.
• Users submit applications to a one-stop service office, with proposals reviewed by referees.
• Researchers are encouraged to discuss projects with PDIS staff prior to application submission.

Main Results:

• PDIS has developed and implemented advanced synchrotron beamlines for micro-crystallography, high-throughput data collection, supramolecular assembly, and native single anomalous dispersion (SAD) phasing.
• Development of specialized beamlines for small-angle X-ray scattering (SAXS) has significantly increased user engagement in bio-SAXS.

Conclusions:

• The PDIS project successfully accelerates structural biology research by providing integrated support and cutting-edge infrastructure.
• The platform's resources and collaborative approach empower researchers, particularly beginners, to advance their structural biology projects.